Waters Corporation

Waters Corporation

Waters Corporation began as a one-man shop in 1958 when James L. Waters established the company in Milford, Massachusetts, to manufacture liquid chromatography instruments. The firm went public in 1968 and grew to become a dominant player in analytical chemistry equipment, with products used by pharmaceutical companies, academic labs, and environmental testing facilities. The founding family's wealth, tied to a substantial stake in the publicly traded company, is managed through a single-family office structure. The family office targets a diversified portfolio including public equities, fixed income, and direct co-investments in life-sciences and healthcare technology companies. Known positions include stakes in publicly traded firms such as Thermo Fisher Scientific (per SEC filings, 2023) and Danaher Corporation (per SEC filings, 2022). The office also participates in venture rounds for early-stage analytical instruments startups, though deal sizes remain undisclosed. Geographically, the focus is predominantly North America, with some exposure to Europe and Asia. The firm operates with a lean team in Milford; exact headcount is not publicly available. Separate from the corporate entity, the James L. Waters Foundation — established in 1998 — supports education and health initiatives in the Boston area, with annual grants totaling approximately $2 million (per foundation records, 2023). No recent operational events were publicly cited. The structural differentiator is the family's ongoing connection to the public company: the family office's liquidity is tied to one specific NYSE-listed stock, creating a concentrated risk profile that the office hedges through derivative strategies. The office also leverages the company's deep scientific network for sourcing proprietary investment opportunities in analytical tools.